skip to the main content area of this page

June 2021 – UNODC: CND decision on international control of isotonitazene enters into force - remaining decisions will enter into force in December 2021

VIENNA, Austria – June 2021:  The decision adopted by the Commission on Narcotic Drugs (CND) during its 64th Session from 12 to 16 April 2021 to add Isotonitazene to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, was communicated by the Secretary-General on 10th of June 2021 to all States Members of the United Nations, to non-member States Parties to the Conventions, to the World Health Organization and to the International Narcotics Control Board and thereby entered into force on the date of receipt of the notification for each party.

The decision adopted by the CND to add CUMYL-PEGACLONE, MDMB-4en-PINACA, 3-Methoxyphencyclidine (3-Meo-PCP) and Diphenidine to Schedule II and Clonazolam, Diclazepam and Flubromazolam to Schedule IV of the Convention on Psychotropic Substances of 1971 will come into force on 7th December 2021. 

For further information please see:

UNODC EWA newsclip: UNODC: Eight substances "scheduled" at the 64th Session of the Commission on Narcotic Drugs

UNODC EWA newsclip: WHO: World Health Organization recommends 8 NPS for scheduling

CND International Drug Conventions

English Advance version of the CND report on the sixty-fourth session


***The Spanish translation of this news item is made possible thanks to a collaboration with OAS/CICAD, a partner of the UNODC EWA.***

go back